ORIGINAL RESEARCH article
Front. Public Health
Sec. Substance Use Disorders and Behavioral Addictions
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1532374
This article is part of the Research TopicInnovations in Recovery Science: Pathways, Policies, and Platforms that Promote Thriving After AddictionView all 21 articles
The linkage between opioid treatment programs (OTPs) and recovery community centers (RCCs): Results of a survey of OTP directors
Provisionally accepted- 1Massachusetts General Hospital, Harvard Medical School, Boston, United States
- 2Massachusetts General Hospital, Boston, Massachusetts, United States
- 3Detroit Recovery Project, Detroit, Michigan, United States
- 4Northern Ohio Recovery Association, Cleveland, Ohio, United States
- 5The PILLARS, New York, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
ObjectiveMedications for opioid use disorder (MOUDs) are regarded as the gold-standard treatment for opioid use disorder in the United States and are widely used in other countries. In the US, the country most impacted by the opioid epidemic, opioid treatment programs (OTPs) are the primary avenue of accessing MOUDs. US federal guidance states that treatment providers should connect patients with recovery community centers (RCCs), if available. RCCs have emerged relatively recently. It is not clear to what extent OTP directors are aware of RCCs. Close collaboration is needed especially in Black communities, as Black Americans face significant disparities in opioid-involved overdoses and deaths.MethodsWe conducted an online survey and interviews of directors of OTPs located near RCCs serving Black communities (operationally defined as located in a ZIP code where ≥25% of residents are Black, as per US Census data). For each such RCC (n=47 nationwide), we used the SAMHSA Treatment Locator to identify and record data (e.g., types of opioid treatment, treatment approaches, in-house recovery support services) about the three nearest OTPs. The survey asked about the OTP’s referral practices to mutual help organizations (MHOs) and recovery support services, knowledge of and interactions with the nearby RCC, and attitudes towards referral to RCCs, including potential barriers to referral. Interviews discussed barriers and potential solutions.ResultsFifteen OTPs completed surveys (32% of targeted locations), and five directors completed interviews. OTPs participating in the survey were comparable to non-participating OTPs on Locator-reported variables. OTPs provided referral to 12-step MHOs (100%); fewer (80%) were familiar with RCCs, provided referral to RCCs (67%), or knew the nearby RCC (40%). OTP directors (100%) reported that routine referral from the OTP to RCCs makes sense and is valuable. Most common barriers were lack of knowledge of RCCs, worries that RCCs may not be supportive of MOUD use, and lack of personnel to build and maintain connections with RCCs. ConclusionEfforts are needed to increase knowledge about RCCs among OTP leadership and staff. Needed knowledge includes general knowledge (i.e., RCCs are welcoming towards MOUDs; RCCs offer complementing support) and logistical information (e.g., RCC opening hours, transportation, that services are free).
Keywords: Recovery community centers, Peer recovery support services, substance use disorder, Recovery, Addiction, definition of recovery
Received: 21 Nov 2024; Accepted: 14 Jul 2025.
Copyright: © 2025 Hoeppner, Williamson, Nicoll, Abboud, Futter, Joseph, Burton, Hickman, Bradley, Pullen, Johnson and Hoeppner. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Bettina Hoeppner, Massachusetts General Hospital, Harvard Medical School, Boston, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.